Amarin Corp Plcuk (AMRN) Notes Payables (2013 - 2014)
Amarin Corp Plc\Uk (AMRN) posted quarterly Notes Payables of $100000.0 for Q4 2014, down 98.55% year-over-year from $6.9 million in Q4 2013, and down 17.36% quarter-over-quarter from $121000.0 in Q3 2014.
Amarin Corp Plcuk (AMRN) Notes Payables (2013 - 2014) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Notes Payables for 2 consecutive years, with $100000.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Notes Payables fell 98.55% year-over-year to $100000.0; the TTM figure through Dec 2014 stood at $100000.0 (down 98.55% YoY), while the FY2014 annual figure was $100000.0, down 98.55% from the prior year.
- Notes Payables slipped to $100000.0 in Q4 2014 per AMRN's latest filing, from $121000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $6.9 million in Q4 2013 and bottomed at $100000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 100,000.00 |
| Sep 30, 2014 | 121,000.00 |
| Jun 30, 2014 | 4.51 Mn |
| Mar 31, 2014 | 5.93 Mn |
| Dec 31, 2013 | 6.89 Mn |